Healthcare >> CEO Interviews >> October 4, 2010
Maurizio Vecchione joined CompuMed, Inc., in June 2007 after serving as a Consultant to the company. Mr. Vecchione serves as a Managing Partner of private equity and venture fund Synthetica Holdings, LLC, and Chairman of Synthetica (America) Ltd., a management consultancy. Mr. Vecchione created significant shareholder value through public transactions, and mergers and acquisitions. He established and led Synthetica's imaging practice, and he served as a Consultant to leading life sciences, medical device and clinical research organizations. From 2004 to 2006, Mr. Vecchione served as President and CEO of Trestle Holdings, a medical imaging and digital pathology company. He also served as CEO of Microwave Photonics, Inc., from 2003 to 2004. In 1998 Mr. Vecchione co-founded medical imaging and rendering company ModaCAD, where he held various senior-level positions and was responsible for architecting numerous rounds of financing, including a significant investment by Intel. In 2001 he executed as Co-CEO the sale of the company to USA Networks for $480 million. Mr. Vecchione was a twice-nominated finalist by Ernst & Young as "Entrepreneur of the Year." He has received many awards, including the British telecommunications Innovation Award and the prestigious DEMOGod Award. Mr. Vecchione has led the development of significant imaging technologies and authored multiple issued patents. Profile
TWST: Please start with a brief history and overview of CompuMed.
Mr. Vecchione: CompuMed (CMPD)is one of the pioneers of telemedicine. Telemedicine is a word that in these days of health care reform
